Mineralys Therapeutics to Announce First Quarter 2026 Financial Results and Host Conference Call on Wednesday, May 6, 2026
Mineralys Therapeutics, a biopharmaceutical company focused on hypertension and related comorbidities, will announce its Q1 2026 financial results after market close on May 6, 2026, followed by a conference call.